Estrogen and Progesterone Receptors, C-ERBB-2, p53, and BCL-2 in Thirty-three Invasive Micropapillary Breast Carcinomas
Authors:
- F. De Los SantosFSF. De Los Santos
- J.J. BretónJBJ.J. Bretón
- M.A. CañadasMCM.A. Cañadas
- 1 January 1996
- journal article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 192 (1) , 27-32
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer. Results from a randomized adjuvant treatment protocolCancer, 1994
- Invasive micropapillary carcinoma of the breastPathology - Research and Practice, 1994
- The Bcl-2 Protein: a Prognostic Indicator Strongly Related to p53 Protein in Lymph Node-Negative Breast Cancer PatientsJNCI: Journal of the National Cancer Institute, 1994
- Prognostic factors in early breast carcinomaCancer, 1994
- c-erbB-2 Amplification and overexpression in breast cancer: evaluation and comparison of southern BLOT, SLOT BLOT, ELISA and immunohistochemistryPathology, 1993
- A simplified histoscore for the estrogen receptor assay in breast cancerPathology - Research and Practice, 1992
- Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast CancersJNCI: Journal of the National Cancer Institute, 1992
- Histological Assessment of the Prognostic Factors in Female Breast CancerOncology, 1992
- p53 alterations in all stages of breast cancerJournal of Surgical Oncology, 1991
- Prognosis and Breast CancerAmerican Journal of Surgical Pathology, 1991